LONDON (Reuters) – Activist hedge fund Elliott Management has taken a multi-billion pound stake in British pharmaceutical firm GlaxoSmithKline, the Financial Times reported on Thursday.
Shares in GSK rose more than 7% on the report. A GSK spokesman was not immediately available to comment.
(Reporting by Alistair Smout; Editing by Keith Weir)